Estrogen-Related Receptor Directs Peroxisome Proliferator-Activated Receptor Signaling in the Transcriptional Control of Energy Metabolism in Cardiac and Skeletal Muscle

Center for Cardiovascular Research, Washington University School of Medicine, St. Louis, MO 63110, USA.
Molecular and Cellular Biology (Impact Factor: 4.78). 11/2004; 24(20):9079-91. DOI: 10.1128/MCB.24.20.9079-9091.2004
Source: PubMed

ABSTRACT Estrogen-related receptors (ERRs) are orphan nuclear receptors activated by the transcriptional coactivator peroxisome proliferator-activated receptor gamma (PPARgamma) coactivator 1alpha (PGC-1alpha), a critical regulator of cellular energy metabolism. However, metabolic target genes downstream of ERRalpha have not been well defined. To identify ERRalpha-regulated pathways in tissues with high energy demand such as the heart, gene expression profiling was performed with primary neonatal cardiac myocytes overexpressing ERRalpha. ERRalpha upregulated a subset of PGC-1alpha target genes involved in multiple energy production pathways, including cellular fatty acid transport, mitochondrial and peroxisomal fatty acid oxidation, and mitochondrial respiration. These results were validated by independent analyses in cardiac myocytes, C2C12 myotubes, and cardiac and skeletal muscle of ERRalpha-/- mice. Consistent with the gene expression results, ERRalpha increased myocyte lipid accumulation and fatty acid oxidation rates. Many of the genes regulated by ERRalpha are known targets for the nuclear receptor PPARalpha, and therefore, the interaction between these regulatory pathways was explored. ERRalpha activated PPARalpha gene expression via direct binding of ERRalpha to the PPARalpha gene promoter. Furthermore, in fibroblasts null for PPARalpha and ERRalpha, the ability of ERRalpha to activate several PPARalpha targets and to increase cellular fatty acid oxidation rates was abolished. PGC-1alpha was also shown to activate ERRalpha gene expression. We conclude that ERRalpha serves as a critical nodal point in the regulatory circuitry downstream of PGC-1alpha to direct the transcription of genes involved in mitochondrial energy-producing pathways in cardiac and skeletal muscle.

Download full-text


Available from: Janice Huss, Nov 20, 2014
16 Reads
    • "Both, in vivo and in vitro functional genomic analysis revealed ERRs as crucial regulators of mitochondrial biogenesis by promoting the transcription of genes involved in almost all aspects of mitochondrial function, including the genes encoding for components of the OxPhos system, the TCA cycle, fatty acid oxidation, mitochondrial dynamics, protein import and mtDNA replication and transcription [73- 75]. Furthermore, it has been shown that ERRs can regulate their own expression [76], in addition to the expression of GAPBα [77] and PPARα [78], resulting in a mechanism that amplifies the transcription of mitochondrial ERR target genes. The generation of knockout mouse models for specific ERR isoforms has confirmed the important role of ERRs in the regulation of mitochondrial biogenesis and function in vivo. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Defects in mitochondrial oxidative function have been associated with the onset of type 2 diabetes. Although the causal relationship between mitochondrial dysfunction and diabetes has not been fully established, numerous studies indicate that improved glucose homeostasis achieved via lifestyle interventions, such as exercise or calorie restriction, is tightly associated with increased mitochondrial biogenesis and oxidative function. Therefore, it is conceivable that potentiating mitochondrial biogenesis by pharmacological means could constitute an efficacious therapeutic strategy that would particularly benefit those diabetic patients who cannot adhere to comprehensive programs based on changes in lifestyle or that require a relatively rapid improvement in their diabetic status. In this review, we discuss several pharmacological targets and drugs that modulate mitochondrial biogenesis as well as their potential use as treatments for insulin resistance and diabetes. Copyright © 2015. Published by Elsevier Inc.
    Biochemical pharmacology 07/2015; DOI:10.1016/j.bcp.2015.06.032 · 5.01 Impact Factor
  • Source
    • "We hypothesize that these TF mediate a highly inter-connected regulatory cascade including pathways such as HIF-1, AR, ER and Wnt/β-catenin that seem pivotal for lipid metabolism. The role of these pathways in the transcriptional regulation of lipid metabolism is a subject of intense studies [17,38,39,51-54]. A functional cooperation between the three TF in the modulation of these pathways is evident from our results and supported by literature evidence. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Fatty acids (FA) play a critical role in energy homeostasis and metabolic diseases; in the context of livestock species, their profile also impacts on meat quality for healthy human consumption. Molecular pathways controlling lipid metabolism are highly interconnected and are not fully understood. Elucidating these molecular processes will aid technological development towards improvement of pork meat quality and increased knowledge of FA metabolism, underpinning metabolic diseases in humans. The results from genome-wide association studies (GWAS) across 15 phenotypes were subjected to an Association Weight Matrix (AWM) approach to predict a network of 1,096 genes related to intramuscular FA composition in pigs. To identify the key regulators of FA metabolism, we focused on the minimal set of transcription factors (TF) that the explored the majority of the network topology. Pathway and network analyses pointed towards a trio of TF as key regulators of FA metabolism: NCOA2, FHL2 and EP300. Promoter sequence analyses confirmed that these TF have binding sites for some well-know regulators of lipid and carbohydrate metabolism. For the first time in a non-model species, some of the co-associations observed at the genetic level were validated through co-expression at the transcriptomic level based on real-time PCR of 40 genes in adipose tissue, and a further 55 genes in liver. In particular, liver expression of NCOA2 and EP300 differed between pig breeds (Iberian and Landrace) extreme in terms of fat deposition. Highly clustered co-expression networks in both liver and adipose tissues were observed. EP300 and NCOA2 showed centrality parameters above average in the both networks. Over all genes, co-expression analyses confirmed 28.9% of the AWM predicted gene-gene interactions in liver and 33.0% in adipose tissue. The magnitude of this validation varied across genes, with up to 60.8% of the connections of NCOA2 in adipose tissue being validated via co-expression. Our results recapitulate the known transcriptional regulation of FA metabolism, predict gene interactions that can be experimentally validated, and suggest that genetic variants mapped to EP300, FHL2, and NCOA2 modulate lipid metabolism and control energy homeostasis in pigs.
    BMC Genomics 03/2014; 15(1):232. DOI:10.1186/1471-2164-15-232 · 3.99 Impact Factor
  • Source
    • "The potential differential expression of these channels in our mice might explain our observations. Sex hormones have been shown to control enzymes implicated in sugar and fatty acid metabolism (Huss et al., 2004). We have seen that the abundance of key enzymes of the glycolytic pathway may be differently regulated in male and female eNOS −/− mice (Vignon-Zellweger et al., 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The nitric oxide and endothelin systems are key components of a local paracrine hormone network in the heart. We previously reported that diastolic dysfunction observed in mice lacking the endothelial nitric oxide synthase (eNOS-/-) can be prevented by a genetic overexpression of ET-1. Sexual dimorphisms have been reported in both ET-1 and NO systems. Particularly, eNOS-/- mice present sex related phenotypic differences. We used the ET-1 transgenic (ET+/+), eNOS-/-, crossbred ET+/+eNOS-/- mice, and wild type controls. We measured cardiac function by heart catheterization. Cardiac ventricles were collected for histological and molecular profiling. We report here that (i) the level of ET-1 expression in eNOS-/- mice was elevated in males but not in females. (ii) Left ventricular end-diastolic blood pressure was higher in male eNOS-/- mice than in females. (ii) eNOS-/- males but not females developed cardiomyocyte hypertrophy. (iv) Perivascular fibrosis of intracardiac arteries developed in female ET+/+ and eNOS-/- mice but not in males. Additionally, (v) the cardiac expression of metalloprotease-9 was higher in eNOS-/-males compared to females. Finally, (vi) cardiac proteome analysis revealed that the protein abundance of the oxidative stress related enzyme superoxide dismutase presented with sexual dimorphism in eNOS-/- and ET+/+ mice. These results indicate that the cardiac phenotypes of ET-1 transgenic mice and eNOS knockout mice are sex specific. Since both systems are key players in the pathogenesis of cardiovascular diseases, our findings might be important in the context of gender differences in patients with such diseases.
    Life sciences 12/2013; 118(2). DOI:10.1016/j.lfs.2013.12.003 · 2.70 Impact Factor
Show more